Magalang, Elvijoy .
HRN: 07-95-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2026
CEFUROXIME 500MG (TAB)
02/17/2026
02/23/2026
PO
500mg
BID
Thinly MSAF
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines